Article Text

PDF
Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years
  1. Katy McConnell1,
  2. Michael Shields2
  1. 1 Paediatric Respiratory Medicine, Royal Belfast Hospital for Sick Children, Belfast, UK
  2. 2 Royal Belfast Hospital for Sick Children, Belfast, UK
  1. Correspondence to Dr Katy McConnell, Paediatric Respiratory Medicine, Royal Belfast Hospital for Sick Children, 274 Grosvenor Road, Belfast BT12 6BA, UK; kt242{at}hotmail.co.uk

Statistics from Altmetric.com

Setting: Birth cohort of general population of Zealand region, Denmark.

Patients: At the age of 1 week, 700 infants were recruited and observed via daily parental diaries until the age of 3 years. Included in the trial were children who developed recurrent troublesome lung symptoms, defined as: 5 episodes in 6 months of cough, dyspnoea or wheeze severely affecting the well-being of the child; 4 weeks of continuous symptoms; severe episode requiring admission or treatment with oral steroids. Three months of inhaled fluticasone was given at the diagnosis of recurrent troublesome lung symptoms and continued for another 6 months if symptoms recurred.

Intervention: Children older than 1 year of age were assessed by a study physician at each acute episode (≥3 consecutive days of cough, dyspnoea or wheeze severely affecting the well-being of the child) and randomly allocated …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.